Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
PURPOSE: To investigate magnetic resonance (MR) volumetry of endometrial tumors and its association with deep myometrial invasion, tumor grade, and lymphovascular invasion and to assess the value of apparent diffusion coefficient (ADC) histographic analysis of the whole tumor volume for prediction of tumor grade and lymphovascular invasion. MATERIALS AND METHODS: The institutional review board approved this retrospective study; patient consent was not required. Between May 2010 and May 2012, 70 women (mean age, 64 years; range, 24-91 years) with endometrial cancer underwent preoperative MR imaging, including axial oblique and sagittal T2-weighted, dynamic contrast material-enhanced, and diffusion-weighted imaging. Volumetry of the tumor and uterus was performed during the six sequences, with manual tracing of each section, and the tumor volume ratio (TVR) was calculated. ADC histograms were generated from pixel ADCs from the whole tumor volume. The threshold of TVR associated with myometrial invasion was assessed by using receiver operating characteristic curves. An independent sample Mann Whitney U test was used to compare differences in ADCs, skewness, and kurtosis between tumor grade and the presence of lymphovascular invasion. RESULTS: No significant difference in tumor volume and TVR was found among the six MR imaging sequences (P = .95 and .86, respectively). A TVR greater than or equal to 25% allowed prediction of deep myometrial invasion with sensitivity of 100% and specificity of 93% (area under the curve, 0.96; 95% confidence interval: 0.86, 0.99) at axial oblique diffusion-weighted imaging. A TVR of greater than or equal to 25% was associated with grade 3 tumors (P = .0007) and with lymphovascular invasion (P < .0001). There was no significant difference in the ADCs between grades 1 and 2 tumors (P > .05). The minimum, 10th, 25th, 50th, 75th, and 90th percentile ADCs were significantly lower in grade 3 tumors than in grades 1 and 2 tumors (P < .02). CONCLUSION: The combination of whole tumor volume and ADC can be used for prediction of tumor grade, lymphovascular invasion, and depth of myometrial invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Morrow, C. P., Bundy, B. N., Kurman, R. J., Creasman, W. T., Heller, P., Homesley, H. D., & Graham, J. E. (1991) · Gynecologic Oncology · doi:10.1016/0090-8258(91)90086-k · Cited by 1,285
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.
Boronow, R. C., Morrow, C. P., Creasman, W. T., DiSaia, P. J., Silverberg, S. G., Miller, A., & Blessing, J. A. (1984) · PubMed · Cited by 589
Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary?
Mariani, A., Webb, M. J., Keeney, G. L., Haddock, M. G., Calori, G., & Podratz, K. C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107335 · Cited by 577 · cited 2×
“In addition, in their study, Mariani et al showed a significant difference in recurrence based on tumor size.”
BackgroundStatistical Evaluation of a Biomarker
Ray, P., Manach, Y. L., Riou, B., Houle, T. T., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d47604 · Cited by 503 · cited 1×
“The cutoff point for the ROC was predetermined by the statistics software to automatically minimize the mathematical distance between the ROC curve and the ideal point, as a method to minimize misclassification of patients (40).”
MethodDonati, O. F., Mazaheri, Y., Afaq, A., Vargas, H. A., Zheng, J., Moskowitz, C. S., Hricak, H., & Akin, O. (2014) · Radiology · doi:10.1148/radiol.13130973 · Cited by 295 · cited 1×
“However, the added benefit of diffusion-weighted imaging (DWI) (15) and quantitative methods have been described in studies of other pelvic cancers (16,17), especially in rectal and cervical cancer (17–19).”
MethodDiffusion‐weighted MR imaging of uterine endometrial cancer
Tamai, K., Koyama, T., Saga, T., Umeoka, S., Mikami, Y., Fujii, S., & Togashi, K. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20997 · Cited by 268 · cited 1×
“Tamai et al (29) described significantly lower ADCs in high-grade tumors than in low-grade tumors, although there were overlaps between grades.”
BackgroundCurvo-Semedo, L., Lambregts, D. M. J., Maas, M., Thywissen, T., Mehsen, R. T., Lammering, G., Beets, G. L., Caseiro-Alves, F., & Beets-Tan, R. G. H. (2011) · Radiology · doi:10.1148/radiol.11102467 · Cited by 265
Kyriazi, S., Collins, D. J., Messiou, C., Pennert, K., Davidson, R. L., Giles, S. L., Kaye, S. B., & deSouza, N. M. (2011) · Radiology · doi:10.1148/radiol.11110577 · Cited by 221 · cited 3×
“In body imaging, Kyriazi et al (34) showed an increase in ADCs and a later decrease in skewness and kurtosis in response to chemotherapy in patients”
BackgroundSala, E., Rockall, A., Rangarajan, D., & Huch, R. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.01.026 · Cited by 221
Self-citationFrei, K. A., Kinkel, K., Bonél, H. M., Lu, Y., Zaloudek, C., & Hricak, H. (2000) · Radiology · doi:10.1148/radiology.216.2.r00au17444 · Cited by 196 · cited 1×
“This protocol has been implemented by most European cancer centers and is also recommended in the European Society of Urogenital Radiology Endometrial Cancer Staging guidelines (5,9,14).”
MethodBeddy, P., Moyle, P., Kataoka, M., Yamamoto, A. K., Joubert, I., Lomas, D., Crawford, R., & Sala, E. (2012) · Radiology · doi:10.1148/radiol.11110984 · Cited by 190 · cited 2×
“In patients with endometrial cancer, DWI has shown promising results (8,27,28) for prediction of deep myometrial invasion, but discordant results have been reported for prediction of tumor grade (29–31).”
ResultSelf-citationStaging of endometrial cancer with MRI: Guidelines of the European Society of Urogenital Imaging
Kinkel, K., Forstner, R., Danza, F. M., Oleaga, L., Cunha, T. M., Bergman, A., Barentsz, J. O., Balleyguier, C., Brkljacic, B., & Spencer, J. A. (2009) · European Radiology · doi:10.1007/s00330-009-1309-6 · Cited by 190 · cited 1×
“This protocol has been implemented by most European cancer centers and is also recommended in the European Society of Urogenital Radiology Endometrial Cancer Staging guidelines (5,9,14).”
MethodAndreano, A., Rechichi, G., Rebora, P., Sironi, S., Valsecchi, M. G., & Galimberti, S. (2014) · European Radiology · doi:10.1007/s00330-014-3139-4 · Cited by 163
Apparent diffusion coefficient histograms may predict low‐grade glioma subtype
Tozer, D. J., Jäger, H. R., Danchaivijitr, N., Benton, C. E., Tofts, P. S., Rees, J. H., & Waldman, A. D. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1091 · Cited by 154 · cited 1×
“For example, Tozer et al (33) showed that ADCs below the 50th percentile histographic mode and skewness allowed discrimination between astrocytomas and oligodendrogliomas.”
MethodDowney, K., Riches, S. F., Morgan, V. A., Giles, S., Attygalle, A. D., Ind, T. E., Barton, D. P. J., Shepherd, J. H., & deSouza, N. M. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9545 · Cited by 139 · cited 4×
“By using this approach, minimum, 10th, 25th, 50th, 75th, and 90th percentile ADCs were significantly lower in grade 3 tumors than in grades 1 and 2 tumors (35).”
BackgroundMethodInfluentialDiffusion-Weighted Magnetic Resonance Imaging of Uterine Cervical Cancer
Liu, Y., Bai, R., Sun, H., Liu, H., & Wang, D. (2009) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31819e93af · Cited by 134
Tozzi, R., Malur, S., Koehler, C., & Schneider, A. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.048 · Cited by 118
Nougaret, S., Rouanet, P., Molinari, N., Pierredon, M.-A., Bibeau, F., Azria, D., Lemanski, C., Assénat, E., Duffour, J., Ychou, M., et al. (2012) · Radiology · doi:10.1148/radiol.12111263 · Cited by 108 · cited 2×
“Studies of tumor volumetry have shown interesting results for tumor response assessment (18,20–23) and the use of tumor volume as a prognostic factor for recurrence and survival (18,20,24,41), especially in patients with rectal and cervical cancer.”
BackgroundMethodSelf-citationInada, Y., Matsuki, M., Nakai, G., Tatsugami, F., Tanikake, M., Narabayashi, I., Yamada, T., & Tsuji, M. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.11.042 · Cited by 105
Yeo, S., Kim, D. Y., Kim, T. H., Jung, K. H., Hong, Y. S., Chang, H. J., Park, J. W., Lim, S.-B., Choi, H. S., & Jeong, S. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1682 · Cited by 87
Kang, J., Kim, Y. C., Kim, H., Kim, Y. W., Hur, H., Kim, J. S., Min, B. S., Kim, H., Lim, J. S., Seong, J., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.066 · Cited by 87
Nougaret, S., Fujii, S., Addley, H. C., Bibeau, F., Pandey, H., Mikhael, H. W., Reinhold, C., Azria, D., Rouanet, P., & Gallix, B. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23905 · Cited by 28
Self-citationCorrelation of three-dimensional tumor volumetry with cervical cancer prognostic parameters.
Chen, A. C. Y., Sung, W. H., Wang, P. H., Sheu, M. H., Doong, J. L., & Yuan, C. (2002) · PubMed · Cited by 21
Cited by
ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma
Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M. R., Marnitz, S., Ledermann, J., Bosse, T., Chargari, C., Fagotti, A., et al. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-002230 · Cited by 1,989
Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology
Nougaret, S., Horta, M., Sala, E., Lakhman, Y., Thomassin-Naggara, I., Kido, A., Masselli, G., Bharwani, N., Sadowski, E., Ertmer, A., et al. (2019) · European Radiology · doi:10.1007/s00330-018-5515-y · Cited by 283
Self-citation
Metadata
- Authors
- Nougaret, S., Reinhold, C., Alsharif, S. S., Addley, H., Arceneau, J., Molinari, N., Guiu, B., & Sala, E.
- Venue
- Radiology
- Published
- 2015-09
- Volume
- 276
- Issue
- 3
- Pages
- 797-808
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2133239823
- Cited by
- 176
- References
- 24
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.